2012Journal of Microwave SurgeryOpen access

Clinical experience of percutaneous radiofrequency ablation of renal cell carcinoma

Hideo Fukuhara, Keiji Inoue, Takashi Karashima, Taro Shuin

Open full text 0 citations

Abstract

Purpose Percutaneous radiofrequency ablation for renal tumor could be a useful modality as minimally invasive and palliative therapy. In this study we evaluated their feasibility and safety.Methods Between 2004 and 2011, real-time CT guided radiofrequency ablation was perfomed to ablate a total of 16 tumors in 13 patients. We recorded whether tumors were successfully ablated, major complications and changes of creatinine clearance before and after RFA.Results Overall 11 of 13 (84.6%) were successfully ablated with radiofrequency ablation but 2 had local recurrent tumors. There was no significant change in creatinine clearance between before and after RFA. Two minor complications as pararenal hemorrhage were observed.Conclusion Percutaneous radiofrequency is a feasible and safe modality as a minimally invasive therapy.

Open-access reader

About this research paper

What this paper is about

Purpose Percutaneous radiofrequency ablation for renal tumor could be a useful modality as minimally invasive and palliative therapy. In this study we evaluated their feasibility and safety.Methods Between 2004 and 2011, real-time CT guided radiofrequency ablation was perfomed to ablate a total of 16 tumors in 13 patients. We recorded whether tumors were successfully ablated, major complications and changes of creatinine clearance before and after RFA.Results Overall 11 of 13 (84.6%) were successfully ablated with radiofrequency ablation but 2 had local recurrent tumors. There was no significant change in creatinine clearance between before and after RFA. Two minor complications as pararenal hemorrhage were observed.Conclusion Percutaneous radiofrequency is a feasible and safe modality as a minimally invasive therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose Percutaneous radiofrequency ablation for renal tumor could be a useful modality as minimally invasive and palliative therapy. In this study we evaluated their feasibility and safety.Methods Between 2004 and 2011, real-time CT guided radiofrequency ablation was perfomed to ablate a total of 16 tumors in 13 patients. We recorded whether tumors were successfully ablated, major complications and changes of creatinine clearance before and after RFA.Results Overall 11 of 13 (84.6%) were successfully ablated with radiofrequency ablation but 2 had local recurrent tumors. There was no significant change in creatinine clearance between before and after RFA. Two minor complications as pararenal hemorrhage were observed.Conclusion Percutaneous radiofrequency is a feasible and safe modality as a minimally invasive therapy.

Key concepts: Medicine, Radiofrequency ablation, Percutaneous, Ablation, Renal cell carcinoma, Radiology, Creatinine, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical experience of percutaneous radiofrequency ablation of renal cell carcinoma — Research Paper | ScholarLens